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The authors regret that an inaccurate version of [Fig. 4](#fig1){ref-type="fig"} appears in the original article. The correct version of [Fig. 4](#fig1){ref-type="fig"} and its legend appear below.

Figure 4.DCs matured in the presence of *Bet.-*APE display reduced Th1- and increased Th2-polarizing capacity. DCs were left untreated or stimulated with *Bet*.-APE (3 mg/ml) in the presence or absence of LPS (100 ng/ml). After 24 h DCs were washed and cocultured with CD4^+^CD45RA^+^ allogenic T cells (DC/T cell ratio 1:4) that were expanded for 12 d in the presence of IL-2. T cell polarization was determined by analyzing intracellular IFN-γ and IL-4 accumulation via flow cytometry after restimulation with PMA and ionomycin in the presence of brefeldin A during the last 2 h of stimulation. To address, if the *Bet.-*APE--dependent Th2 polarization could be reverted by exogenous IL-12, hrIL-12 (10 ng/ml) was added at the beginning of the coculture of *Bet*.-APE/LPS-treated DCs and T cells. Representative experiment of *n* = 3--6 (compare Table I). To explore the role of IL-4 in the Th2 polarization induced by *Bet*.-APE--treated DCs, IL-4--neutralizing antibodies (10 μg/ml) were added at the beginning of the DC/T cell coculture. Representative experiment of *n* = 3.
